STAT

JANUARY 10, 2023

Five studies co-authored by Tessier-Lavigne are now under the microscope for containing alleged altered images: a 1999 Cell study , a 2008 paper in the EMBO Journal, a 2003 Nature study, and two studies published in 2001 in Science.

332

332

STAT

MARCH 31, 2023

Indeed, academic inventors or founders contributed to more than one-quarter of all medicines approved from 2001 through 2019. Academia can be an excellent source of novel drug targets and new technologies that can enhance medicinal discovery. Yet many sponsored research collaborations that hope to tap into academia fail.

Drug Development 267

Drug Development 267

STAT

JUNE 15, 2023

The Centers for Disease Control and Prevention report examined the homicide and suicide rates among 10- to 24-year-olds from 2001 to 2021. The homicide rate for older U.S. Read the rest…

246

246

STAT

DECEMBER 12, 2022

The deal is the largest pharma merger announced this year, and it represents the most that Amgen has spent on an acquisition since its $16 billion purchase of Immunex in 2001. Amgen said Monday it would purchase Horizon Pharmaceuticals for $27.8 Continue to STAT+ to read the full story…

Pharmaceutical Companies 252

Pharmaceutical Companies Pharmaceutical Companies 252

STAT

AUGUST 8, 2023

The study, published last week in The Lancet Psychiatry , analyzed answers that participants provided between 2001 and 2022 in response to a World Health Organization survey designed to assess the prevalence of major mental health disorders.

246

246

STAT

JANUARY 31, 2023

The program is widely considered a success and has worked well for many drugs, including the leukemia drug Gleevec , which the FDA approved in 2001 after a review period of just two-and-a-half months, based on study results that correctly predicted successful clinical outcomes. Continue to STAT+ to read the full story…

Drug Pricing 246

Drug Pricing 246

STAT

FEBRUARY 13, 2024

In 2001, Gilead secured FDA approval of tenofovir disoproxil fumarate (TDF), one of first medicines to treat HIV — a product still on the market, despite the potential side effect of causing skeletal and kidney damage.

Drug Development 295

Drug Development 295

STAT

JULY 17, 2023

The study was shut down early — and a year later, prescriptions had plummeted to nearly half what they had been in 2001.  But in 2002, the therapy went into a free-fall when a landmark trial suggested treating menopause with estrogen and progesterone increased the risk of breast cancer and cardiovascular disease.

246

246

STAT

JULY 10, 2025

The drug, called ISB 2001, targets CD38 and BCMA protein receptors on tumor cells and the CD3 receptor on T cells. AbbVie is paying $700 million upfront to acquire licensing rights to a “trispecific antibody” treatment for cancer developed by Ichnos Global Innovation. A Phase 1 study in multiple myeloma is underway.

Biosimilars 161

Biosimilars Drug Pricing Drug Development 161

STAT

DECEMBER 12, 2022

The deal is the largest pharmaceutical merger announced this year, and it represents the most that Amgen has spent on an acquisition since its $16 billion purchase of Immunex in 2001. The The product is expected to generate $1.97 billion in 2022 and $2.26 billion in 2023, according to FactSet, an investment data firm.

246

246

STAT

APRIL 11, 2024

stood at 323 during the fourth quarter of last year — the highest figure reached since such data began being tracked in 2001 — underscoring growing concerns about patient harm across the country, STAT tells us. Unresolved The number of ongoing and active drug shortages in the U.S.

Chemotherapy 259

Chemotherapy Immunity Immunization 259

Express Pharma

FEBRUARY 14, 2025

Pillai (2013), poet-translator Madan Lal Madhu (2001), former Prime Minister Inder Kumar Gujral, Justice V.R. Dr Saxena joins an eminent group of Indians who have received the Order of Friendship , including chess grandmaster Viswanathan Anand (2018), former Member of Parliament Murli Manohar Joshi, scientist Dr A.S.

103

103

Pharmacy Times

JUNE 27, 2025

With the Advisory Committee on Immunization Practices recommending that adults receive thimerosal-free influenza vaccines, the preservative that was phased out of most childhood vaccines in 2001 has reentered the public eye.

Vaccines 45

Vaccines Immunity Immunization 45

European Pharmaceutical Review

OCTOBER 19, 2023

The Investigational New Drug (IND) application for Intellia Therapeutics’ in vivo CRISPR-based candidate NTLA-2001, has been cleared as a gene editing therapy for transthyretin (ATTR) amyloidosis with cardiomyopathy (ATTR-CM) in the US. This supports NTLA-2001’s potential as a single-administration therapeutic.

105

105

Safe Biologics

JULY 7, 2025

Department of Health and Services (HHS) from 2001 to 2008. ARLINGTON, VA — July 7, 2025 — The Alliance for Safe Biologic Medicines (ASBM) today announced the retirement of longtime Board member Doug Badger, and the appointment of two new members to its Board of Directors: Cristina V.

113

113

Express Pharma

DECEMBER 9, 2024

The post Ichnos Glenmark Innovation presents first clinical data from phase 1 study of Trispecific TREAT Antibody, ISB 2001 appeared first on Express Pharma.

Immunity 52

Immunity Immunization Hospitals Labelling 52

NY Times

DECEMBER 2, 2021

In 2001, U.N. estimates suggested 150 million people would be infected with H.I.V. That preceded an ambitious global campaign to curb the virus. How well did it work?

Immunity 89

Immunity Immunization 89

PharmaShots

APRIL 3, 2023

REGiMMUNE’s RGI-2001 is currently in P-III trial for the prophylaxis of aGVHD Ref: Businesswire | Image: Regimmune Related News:- Omega Therapeutics Entered into a Clinical Supply Agreement with Roche to Evaluate OTX-2002 for Hepatocellular Carcinoma

40

40

Outsourcing Pharma

JULY 26, 2023

Leslie Orne joined Trinity Life Sciences in 2001 and was recently appointed CEO and president of the fast-growing healthcare consultancy. She previously held the title of chief commercial officer (CCO) and president.

81

81

pharmaphorum

JUNE 28, 2021

Preliminary results from a phase 1 trial run by Regeneron and CRISPR specialist Intellia Therapeutics – co-founded by Nobel Prize winner Jennifer Doudna – showed steep reductions in a biomarker of ATTR amyloidosis disease activity with a single dose of the NTLA-2001 drug.

Packaging 105

Packaging 105

ALiEM - Pharm Pearls

SEPTEMBER 30, 2024

2001 Dec;59(12):1462-70. However, non-traumatic hyphema should prompt investigation for hematologic disorders such as Sickle cell disease. References Brandt MT, Haug RH. Traumatic hyphema: a comprehensive review. J Oral Maxillofac Surg. doi: 10.1053/joms.2001.28284. 2001.28284. PMID: 11732035. Gragg J, Blair K, Baker MB. 2022 Dec 26.

161

161

European Pharmaceutical Review

MAY 15, 2025

This treatment is designed to address the underlying orexin deficiency in the chronic neurological condition, according to Takeda.

Hospitals 52

Hospitals 52

Pharmacy Times

MAY 8, 2025

The agent demonstrated promising tolerability and manageable safety.

32

32

Pharmaceutical Technology

NOVEMBER 18, 2024

Intellia presented data from its Phase I study of NTLA-2001 at the 2024 American Heart Association scientific meeting in Chicago.

52

52

European Pharmaceutical Review

MAY 27, 2025

The Irish medicines regulatory agency, requested this action under Article 31 of Directive 2001/83/EC. Start of referral The CHMP has started a review of available information on the benefits and risks of ipidacrine-containing medications, largely indicated to treat disorders affecting the nervous system.

Biosimilars 59

Biosimilars Generic Medicine 59

Pharmacy Times

MAY 8, 2024

Ongoing and active shortages are currently at the highest number since January 2001.

52

52

Pharmaceutical Technology

JULY 10, 2023

The US FDA has granted orphan drug designation (ODD) for Ichnos Sciences’ ISB 2001 to treat patients with multiple myeloma.

52

52

pharmaphorum

DECEMBER 1, 2022

Led by the MPE CEE Workgroup on Access, the report – Addressing access barriers to myeloma clinical trials in Central and Eastern Europe – evaluated the number of clinical trials held in CEE countries between 1 January 2001 and 28 September 2020. Approximately 50,000 people in Europe are diagnosed with myeloma each year.

72

72

Beckers Hospital Review

JULY 2, 2025

He joined Franciscan in 2001 during his residency and has served in various leadership roles, most recently as medical director of information services. He previously served as CEO of Presence Health, where he led a $210 million financial turnaround. Joseph Schnecker, MD, has been promoted to chief medical information officer.

Hospitals 52

Hospitals 52

European Pharmaceutical Review

JUNE 24, 2022

Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use. One of the key priorities of the EU’s strategy is to encourage innovation to solve unmet medical needs. Brussels; 2020.

Compounding 105

Compounding Drug Development Drug Pricing Dosage 105

European Pharmaceutical Review

APRIL 13, 2023

For example, the relaxed attitude towards cannabis in the Netherlands is well-known and Portugal has decriminalised the possession and consumption of all illicit substances since 2001.

Biosimilars 131

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 131

pharmaphorum

NOVEMBER 18, 2020

Since being founded in 2001, Envision has delivered strong year-on-year organic growth and established leadership in medical affairs strategy, medical communications, and enterprise-wide Envision technology.

Communication 72

Communication Pharmaceutical Companies Pharmaceutical Companies 72

Pharmacy Joe

JANUARY 24, 2024

For example, if the new article is about glucose control in the ICU, you can be sure that the letter to the editor will mention other landmark trials such as 2001 article by Van Den Berghe and NICE-SUGAR.

Inpatient 98

Inpatient Hospitals 98

pharmaphorum

OCTOBER 13, 2020

Since it was founded in 2001 the company has become one of the country’s best known biotechs thanks to its approach to designing drugs based around network biology.

Diabetes 101

Diabetes 101

European Pharmaceutical Review

JANUARY 25, 2024

Proposal for a Directive of the European Parliament and of the Council on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC.” References European Commission, (26 April 2023). Article 63 EMA (29 January 2020). Article 63 Euractiv (26 September 2023).

Packaging 98

Packaging Documentation Communication Pharmaceutical Companies 98

pharmaphorum

JANUARY 6, 2022

H3B-8800 – now renamed RVT-2001 – will be taken in a slightly different direction by Roivant, which said it plans to develop it as a therapy for transfusion-dependent anaemia in patients with lower-risk MDS, according to the company.

Compounding 52

Compounding Drug Development 52

RX Note

MARCH 31, 2025

External Links American Academy of Dermatology Association - Cold Sores Antiviral activity of Australian tea tree oil and eucalyptus oil against herpes simplex virus in cell culture, 2001 Natural remedies for Herpes simplex, 2006 Randomized clinical study comparing Compeed cold sore patch to acyclovir cream 5% in the treatment of herpes simplex labialis, (..)

Community Pharmacies 52

Community Pharmacies Chemotherapy 52